csic.org.uk

  • Decrease font size
  • Default font size
  • Increase font size
New Breakthrough in Treating MG
What is Myasthenia Gravis PDF Print E-mail
Written by Chris Constantine   
Thursday, 29 May 2008 07:58
Article Index
What is Myasthenia Gravis
Signs and Symptoms
Diagnosis
Classification
Associations
Usual Medical Approach / Treatment
Epidemiology
All Pages

Myasthenia gravis (literally "serious muscle-weakness"; from Greek "muscle", "weakness", and Latin gravis "serious"; abbreviated MG) is a neuromuscular disease leading to fluctuating muscle weakness and fatiguability. It is an autoimmune disorder, in which weakness is caused by circulating antibodies that block acetylcholine receptors at the post-synaptic neuromuscular junction, inhibiting the stimulative effect of the neurotransmitter acetylcholine. Myasthenia is treated medically with cholinesterase inhibitors or immunosuppressants, and, in selected cases, thymectomy. At 200-400 cases per million it is one of the less common autoimmune disorders.

 



Last Updated ( Saturday, 31 May 2008 18:09 )